Infants born to mothers with hepatitis B have a 70 to 90% risk of acquiring infection during delivery unless the infants are treated with hepatitis B immune globulin (HBIG) and are vaccinated after delivery; risk is also decreased by treating actively infected third trimester pregnant mothers who have high viral loads with tenofovir.